For ads-free news, click here.
From Fox News: A major agency within the Department of Health and Human Services (HHS) sent a memo to hospitals and medical providers in the U.S. this week reminding them of “the dangerous chemical and surgical mutilation of children, including interventions that cause sterilization,” and vowed the agency would continue aligning its policies with President Donald Trump’s executive orders.
The Centers for Medicare and Medicaid Services (CMS), which provides health coverage to more than 100 million people through Medicare, Medicaid and the Children’s Health Insurance Program, sent a memo Wednesday that was obtained by Fox News Digital reiterating “the program requirements of hospitals to serve all patients, especially children, with dignity and adherence to the highest standard of care that is informed by robust evidence and the utmost scientific integrity.” The memo is effective immediately.
“Other developed nations have taken decisive actions to prohibit or significantly limit these mutilation practices to ensure that children are protected from harmful, unscientific medical interventions,” the memo adds.
A press release shared by HHS reads:
Today, the Centers for Medicare & Medicaid Services (CMS) alerted providers of their obligation to protect American children from often irreversible chemical and surgical mutilation, including interventions that cause sterilization. Hospital providers were alerted of serious quality and safety concerns associated with harmful, medical interventions for gender dysphoria. CMS also announced it may begin taking steps to align its policies and regulations with medical evidence and to safeguard children from often irreversible experiments. CMS will continue to follow any applicable substantive and procedural requirements in taking any future action.
Recent studies found that between 2017 to 2021, more than 120,000 children ages 6 to 17 were diagnosed with gender dysphoria and, of that group, more than 17,000 started taking puberty blockers or cross-sex hormones.1 CMS notes research that shows the potentially harmful long-term effects of those puberty blockers related to children’s growth spurts, bone growth, bone density, and fertility.2 CMS also explains how the U.S. is now an outlier in the treatment of gender dysphoria in children. The United Kingdom, Sweden, and Finland have recently issued restrictions on these interventions for children, including the use of puberty blockers and cross-sex hormones.
CMS reminds hospitals that it is of utmost importance that all providers follow the highest standards of care and adhere closely to the foundational principles of medicine in doing no harm, especially as it comes to America’s children. CMS may take additional appropriate actions to protect children from chemical and surgical mutilation and to appropriately update its policies.
CMS sent providers a quality & safety advisory alerting them to the risks to American children from chemical & surgical mutilation. It is of utmost importance that all providers follow the highest standards of care. https://t.co/s7XyV0ukxP
— CMSGov (@CMSGov) March 6, 2025
Hospitals warned they must protect children from chemical and surgical mutilation: HHS agency memo https://t.co/Fw9y9l04dY
— Fox News (@FoxNews) March 7, 2025
Follow us on X (Formerly Twitter.)
The DML News App: www.X.com/DMLNewsApp
The Dennis Michael Lynch Podcast archive is available below, with the most recent on top. Never miss an episode. Subscribe to the show by downloading The DML News App or go to Apple Podcasts.
